John Maraganore
CEO
CEO
Board Member
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Alnylam Pharmaceuticals, Inc. (ALNY) | Former ChiefExecutive Officer (principal executive officer) | $948,500 | $10,176,685 |
| 2020 | Alnylam Pharmaceuticals, Inc. (ALNY) | Former ChiefExecutive Officer (principal executive officer) | $946,200 | $7,818,164 |
| 2019 | Alnylam Pharmaceuticals, Inc. (ALNY) | Former ChiefExecutive Officer (principal executive officer) | $845,000 | $7,317,856 |
| 2018 | Alnylam Pharmaceuticals, Inc. (ALNY) | Chief Executive Officer(principal executive officer) | $800,000 | $5,089,269 |
| 2017 | Alnylam Pharmaceuticals, Inc. (ALNY) | Ph.D. Chief ExecutiveOfficer (principal executive officer) | $753,548 | $1,417,394 |
Executive changes
Earnings-call appearances
-
Alnylam Pharmaceuticals, Inc. Q3 FY2021 Earnings Call2021-10-28
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q2 FY2021 Earnings Call2021-08-03
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q1 FY2021 Earnings Call2021-04-29
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q4 FY2020 Earnings Call2021-02-11
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q3 FY2020 Earnings Call2020-11-05
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q2 FY2020 Earnings Call2020-08-06
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q1 FY2020 Earnings Call2020-05-06
Alnylam Pharmaceuticals, Inc. (ALNY)